Last reviewed · How we verify
NCT05286736
Neuroplasticity in Parkinson's Disease
trial testing Neuroimaging in Parkinson in 50 participants. Currently enrolling.
9 July 2026
Quick facts
| Lead sponsor | University of Minnesota |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 March 2021 |
| Primary completion | 9 July 2026 |
| Estimated completion | 9 November 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Neuroimaging
- Quantitative assessments
Conditions studied
- Parkinson — all drugs for Parkinson →
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
University of Minnesota
Who can join
Adults 21 to 75, any sex, with Parkinson or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this project is to increase our understanding of the early state and temporal evolution of neuroplastic changes in the cortex and subthalamic nucleus (STN) of people with PD, and the relationship of these changes to the emergence and expression of PD motor and non-motor signs. Neurophysiological biomarkers derived from this work may be important for the early detection and prediction of progression of disease. They can also provide the means to assess the efficacy of interventions designed to prevent or slow disease progression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05286736
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neuroimaging
Trials testing the same drug.
- NCT07336992 — Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: · Phase 3 · not yet recruiting
- NCT06874231 — Brain Connectivity Marker for Alzheimer's Disease · recruiting
- NCT05698537 — Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda · completed
- NCT05322343 — Biobank and Brain Health in Bordeaux. · recruiting
- NCT04989608 — Correlation Between Cognition and Neuroimaging in TIA Patients · NA · recruiting
Other recruiting trials for Parkinson
Currently open trials in the same condition.
- NCT07402928 — Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's · recruiting
- NCT07148700 — Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functi · recruiting
- NCT05931692 — Virtual Reality and Fear of Falling in Parkinson's Disease · recruiting
- NCT03672266 — Studies of Brain and Body Interaction · recruiting
Other University of Minnesota trials
Trials by the same sponsor.
- NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
- NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
- NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05286736 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
- Last refreshed: 8 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05286736.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing